[1] Kennedy J. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer. 2005; 5: 321-327.
[2] Illing R, Kennedy J, Wu F, Haar G, Protheroe A, Friend P, Gleeson F, Cranston D, Phillips R, Middleton M. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population, Brit. J. Cancer. 2005; 93: 890-895.
[3] Wu F. High intensity focused ultrasound: A noninvasive therapy for locally advanced pancreatic cancer. World. J. Gastro. 2014; 20: 16480.
[4] Li C, Zhang W, Fan W, Huang J, Zhang F, Wu P. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer. 2010 ;116:3934-3942.
[5] Al-Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer. Treat .Rev. 2012;38:346-353.
[6] Burke A, Singh R, Carroll D, Wood J, D’Agostino Jr R, Ajayan P, Torti F, Torti S. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012; 33: 2961-2970.
[7] Calderwood S, Gong J. Trends. Biochem.Sci. 2016; 41: 311-323.
[8] Jego G, Hazoumé A, Seigneuric R, Garrido C. A mitochondrial-metabolism-regulatable carrier-free nanodrug to amplify the sensitivity of photothermal therapy. Cancer. Lett. 2013 ;332:275-285.
[9] N. Tempel, M. Horsman, R. Kanaar, Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms, Inter J Hyperther 2016 (32) 446-454.
[10] Hu J, Cheng Y, Zhang X. Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale. 2018; 10:22657-22672.
[11] Wu D, Jin X, Wang X, Ma B, Lou C, Qu H, Zheng J, Zhang B, Yan X, Wang Y, Jing L. Engineering temperature-sensitive plateletsomes as a tailored chemotherapy platform in combination with HIFU ablation for cancer treatment. Theranostics. 2019; 9:3966.
[12] Shin S, Park S, Kim S, Kim M, Kim D. Fluorine MR Imaging Monitoring of Tumor Inflammation after High-Intensity Focused Ultrasound Ablation. Radiology. 2018; 287: 476-484.
[13] Illing R, Kennedy J, Wu F, Haar G, Protheroe A, Friend P, Gleeson F, Cranston D, Phillips R, Middleton M. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Brit. J. Cancer. 2005;93: 890-895.
[14] Balkwill F, Charles K, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer. cell. 2005; 7: 211-217.
[15] Roxburgh C, McMillan D. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat. Rev. 2012;38: 451-466.
[16] Hiller J, Perry N, Poulogiannis G, Riedel B, Sloan E. Perioperative events influence cancer recurrence risk after surgery. Nat. Rev. Clin. Oncol. 2018;15:205-218.
[17] Zhou J, Zhao W, Miao Z, Wang J, Ma Y, Wu H, Sun T, Qian H, Zha Z. Folin–Ciocalteu Assay Inspired Polyoxometalate Nanoclusters as a Renal Clearable Agent for Non-Inflammatory Photothermal Cancer Therapy. ACS nano. 2020;14: 2126-2136.
[18] Li Z, Chen Y, Sun Y, Zhang X. Platinum-Doped Prussian Blue Nanozymes for Multiwavelength Bioimaging Guided Photothermal Therapy of Tumor and Anti-Inflammation. ACS nano. 2021; 15: 5189-5200.
[19] Wang S, Zhang C, Chen Z, Ye J, Peng S, Rong L, Liu C Zhang X. A Versatile Carbon Monoxide Nanogenerator for Enhanced Tumor Therapy and Anti-Inflammation. ACS nano. 2019 ;13: 5523-5532.
[20] Luo W, Zhou X, Ren X, Zheng M, Zhang J, He G. Role of enhanced US in evaluating therapeutic response of uterine leiomyoma treated with HIFU. J. Ultras. Med. 2007;26: 419-426.
[21] Xu J, Chen Y, Deng L, Liu J, Cao Y, Li P, Ran H, Zheng Y, Wang Z. Microwave-activated nanodroplet vaporization for highly efficient tumor ablation with real-time monitoring performance. Biomaterials. 2016 ;106:264-275.
[22] Ma M, Xu H, Chen H, Jia X, Zhang K, Wang Q, Zheng S, Wu R, Yao M, Cai X, Li F, Shi J. A drug–perfluorocarbon nanoemulsion with an ultrathin silica coating for the synergistic effect of chemotherapy and ablation by high‐intensity focused ultrasound. Adv. Mater. 2014;26: 7378-7385.
[23] K. Zhang, P. Li, H. Chen, X. Bo, X. Li and H. Xu, Continuous Cavitation Designed for Enhancing Radiofrequency Ablation via a Special Radiofrequency Solidoid Vaporization Process, Acs Nano 2016 (10) 2549-2558.
[24] Wang X, Chen H, Zheng Y, Ma M, Chen Y, Zhang K, Zeng D, Shi J. Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation. Biomaterials. 2013 ;34: 2057-2068.
[25] Hsu P, Sabatini D. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134: 703-707.
[26] Lincet H, Icard P. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene. 2015 ;34:3751-3759.
[27] Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R, Ding J, Tong L, Wu S. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol. Cancer. Ther. 2012; 11: 1672-1682.
[28] Hu L, Zhang X, Jiang S, Tao L, Li Q, Zhu L, Yang M, Huo Y, Jiang Y, Tian G. Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin. Cancer. Res. 2019 ;25: 1318-1330.
[29] Zhang T, Wu B, Akakuru O, Yao C, Sun S, Chen L, Ren W, Wu A, Huang P. Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer. Cancer. Lett. 2021 ;500: 41-50.
[30] Ma Y, Zhou J, Miao Z, Qian H, Zha Z. DL-Menthol Loaded Polypyrrole Nanoparticles as a Controlled Diclofenac Delivery Platform for Sensitizing Cancer Cells to Photothermal Therapy. ACS. Appl. Bio. Mater. 2019 ;2: 848-855.
[31] Jiang A, Liu Y, Ma L, Mao F, Liu L, Zhai X, Zhou J. Biocompatible heat-shock protein inhibitor-delivered flowerlike short-wave infrared nanoprobe for mild temperature-driven highly efficient tumor ablation. ACS. Appl. Mater. Inter. 2019;11:6820-6828.
[32] Gao G, Jiang Y, Guo Y, Jia H, Cheng X, Deng Y, Yu X, Zhu Y, Guo H, Sun W. Enzyme‐mediated tumor starvation and phototherapy enhance mild‐temperature photothermal therapy. Adv. Funct. Mater. 2020;30: 1909391.
[33] Gottfried E, Lang S, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A. New aspects of an old drug–diclofenac targets MYC and glucose metabolism in tumor cells. PloS one. 2013;8: e66987.
[34] Coussios C, Farny C, Haar G, Roy R. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Inter. J. Hyperther. 2007;23: 105-120.
[35] Zhang K, Chen H, Li F, Wang Q, Zheng S, Xu H, Ma M, Jia X, Chen Y, Mou J, Wang X, Shi J. A continuous tri-phase transition effect for HIFU-mediated intravenous drug delivery. Biomaterials. 2014 ;35: 5875-5885.
[36] Zhang K, Li P, He Y, Bo X, Li X, Li D, Chen H, Xu H. Synergistic retention strategy of RGD active targeting and radiofrequency-enhanced permeability for intensified RF & chemotherapy synergistic tumor treatment. Biomaterials. 2016;99: 34-46.
[37] Gao M, Liang C, Song X, Chen Q, Jin Q, Wang C, Liu Z. Erythrocyte‐membrane‐enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv. Mater. 2017;29: 1701429.
[38] Chen Y, Liang Y, Jiang P, Li F, Yu B, Yan F. Lipid/PLGA hybrid microbubbles as a versatile platform for noninvasive image-guided targeted drug delivery. ACS. Appl. Mater. Inter. 2019;11:41842-41852.
[39] Chen W, Luo G, Lei Q, Hong S, Qiu W, Liu L, Cheng S, Zhang X. Overcoming the heat endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal therapy. ACS nano. 2017;11: 1419-1431.
[40] Young C, Lewis A, Rudolph M, Ruehle M, Jackman M, Yun U, Ilkun O, Pereira R, Abel E, Anderson S. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PloS one. 2011;6: e23205.
[41] Tsirkin S, Goldbart R, Traitel T, Kost J. Tailor-Made Single-Core PLGA Microbubbles as Acoustic Cavitation Enhancers for Therapeutic Applications. ACS. Appl. Mater. Inter. 2021;13: 25748-25758.
[42] Dancy J, Wadajkar A, Connolly N, Galisteo R, Ames H, Peng S, Tran N, Goloubeva O, Woodworth G, Winkles J, Kim A. Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer. Sci. Adv. 2020;6: eaax3931.
[43] Gan T. Diclofenac: an update on its mechanism of action and safety profile, Curr. Med .Res. Opin. 2010;26:1715-1731.
[44] Roshani A, Falahatkar S, Khosropanah I, Roshan Z, Zarkami T, Palizkar M, Emadi S, Akbarpour M, Khaki N. Assessment of clinical efficacy of intranasal desmopressin spray and diclofenac sodium suppository in treatment of renal colic versus diclofenac sodium alone. Urology. 2010;75:540-542.